Novozymes is the world leader in bioinnovation. Our business is industrial enzymes, microorganisms, and biopharmaceutical ingredients. We help companies make more from less as our solutions save energy and raw materials, and reduce waste. The result is higher quality, lower costs, and a better environment. Our biological solutions are used in the production of numerous products such as biofuels, detergents, food, and animal feed.
In 2009, we achieved revenue of DKK 8,448 million based on a large portfolio of products and services worldwide. Our business consists of two segments: Enzyme Business and BioBusiness. Around 14% of our revenue is spent on research and development, and we currently hold more than 6,000 patents, which indicates the possibilities when nature and technology join forces. We number over 5,200 employees globally.
For more information, download the brochure Novozymes Facts.
Figures
|
2008
|
2009 |
| Sales |
DKK 8,146 million |
DKK 8,448 million |
| Operating profit |
DKK 1,504 million |
DKK 1,688 million |
| Net profit |
DKK 1,062 million |
DKK 1,194 million |
| Operating profit margin |
18,5% |
20.0% |
| Free cash flow before acquisitions as a percentage of sales |
755 |
839 |
| ROIC |
19,5% |
20.3% |
|
Water consumption, 1,000 m3 |
5,693 |
5,064 |
| Energy consumption, 1,000 GJ |
4,009 |
3,530 |
| Frequency of occupational accidents |
4.9 |
5,1 |
Our management team (please read more here)
Steen Riisgaard
President and CEO
Per Falholt
Executive Vice President and CSO
Benny Dalgaard Loft
Executive Vice President and CFO, Investor Relations, IT and Legal Affairs
Peder Holk Nielsen
Executive Vice President for Enzymes Business
Thomas Videbæk
Executive Vice President for BioBusiness
Thomas Nagy
Executive Vice President for Stakeholder Relations
Ownership
The Novozymes A share capital is held by Novo A/S, a wholly-owned subsidiary of the Novo Nordisk Foundation. In addition, Novo A/S holds 5,826,280 B shares, which overall gives Novo A/S 25.5% of the total share capital and 70.1% of the votes.
Read more share information
here.